I would advise caution on these numbers. The 3500 patients p.a is Japan's estimated TOTAL addressable market. The 1000 patient figure represents a somewhat more realistic figure HOWEVER these things take time to set up, train doctors, distribute and make the market even aware of the product.
I would expect it to be like turning a tap. Medicine is a slow field to change, don't expect much in the first year.
My estimates for Japan only;
Year 1 - 50 to 200 patients
Year 2 - 200 to 500
Year 3 - 500 to 750
Year 4 - 750 to 1000
Remember many people don't have the necessary insurance, can't make the co-payment or simply can't afford it.
Note: Global Data estimates GLOBAL GvHD therapeutics market at $261.6m in 2010, growing to $615.1m in 2018 (msb 29th April 2014). Japan is a tiny fraction of that market.
- Forums
- ASX - By Stock
- Revenue from Japan
I would advise caution on these numbers. The 3500 patients p.a...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
94.0¢ |
Change
-0.060(6.00%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
99.0¢ | 99.5¢ | 93.5¢ | $5.643M | 5.894M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 72266 | 93.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 72266 | 0.935 |
14 | 213971 | 0.930 |
4 | 81889 | 0.925 |
9 | 81076 | 0.920 |
3 | 73254 | 0.915 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 20000 | 1 |
0.950 | 124011 | 4 |
0.955 | 86289 | 3 |
0.960 | 61289 | 3 |
0.965 | 40000 | 1 |
Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |